NovaBay Pharmaceuticals, Inc. (NBY) (CIK 0001389545) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001437749-25-036356
- Form
- CORRESP
- Filer
- NovaBay Pharmaceuticals, Inc. (NBY) (CIK 0001389545)
- CIK
- 0001389545
- Ticker
- NBY
- Filed
- 2025-11-25
- SIC industry
- 2834
- HQ
- Emeryville, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1389545/000143774925036356/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗